Carrick Therapeutics
@carricktherapeutics.com
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.
Carrick Therapeutics's Company Logos
Carrick Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#50BBA9
Fountain Blue
80, 187, 169
170, 44, 52
57, 0, 10, 27
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#007A55
Tropical Rain Forest
0, 122, 85
162, 100, 24
100, 0, 30, 52
About Carrick Therapeutics
Carrick Therapeutics is a clinical-stage biopharmaceutical brand based in Ireland, dedicated to developing innovative therapies for aggressive and resistant forms of cancer. With a strong foundation of like-minded scientists, collaborators, and investors, Carrick Therapeutics aims to transform the way cancer is treated by introducing ground-breaking cancer therapies worldwide. Through understanding the mechanisms that cause cancer and utilizing cutting-edge technologies, Carrick identifies therapeutics and patients who would benefit most from their treatments.
They explore novel molecules and pathways to target the most aggressive forms of cancer, with a particular focus on breast, prostate, ovarian, pancreatic, and other types of cancer. Carrick Therapeutics builds strong partnerships and leverages its external collaborations to advance its programs, from licensing assets to conducting clinical trials. The brand's leadership team, comprised of pharmaceutical professionals with extensive industry experience, ensures the successful development of therapies, from discovery to commercialization.
Carrick Therapeutics is committed to making a significant impact on the lives of patients and offering hope in the fight against cancer
Company type
Privately Held
Year founded
2015
Company size
2-10 employees
